- Home
- RGF vs ADXN Comparison
RGF vs ADXN Comparison
Compare RGF & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGF
- ADXN
- Stock Information
- Founded
- RGF 2016
- ADXN 2002
- Country
- RGF United States
- ADXN Switzerland
- Employees
- RGF N/A
- ADXN N/A
- Industry
- RGF Packaged Foods
- ADXN Biotechnology: Pharmaceutical Preparations
- Sector
- RGF Consumer Staples
- ADXN Health Care
- Exchange
- RGF Nasdaq
- ADXN Nasdaq
- Market Cap
- RGF 8.3M
- ADXN 11.3M
- IPO Year
- RGF 2021
- ADXN N/A
- Fundamental
- Price
- RGF $0.36
- ADXN $11.26
- Analyst Decision
- RGF Hold
- ADXN Strong Buy
- Analyst Count
- RGF 1
- ADXN 1
- Target Price
- RGF $0.50
- ADXN $30.00
- AVG Volume (30 Days)
- RGF 1.2M
- ADXN 24.7K
- Earning Date
- RGF 11-08-2024
- ADXN 11-11-2024
- Dividend Yield
- RGF N/A
- ADXN N/A
- EPS Growth
- RGF N/A
- ADXN N/A
- EPS
- RGF N/A
- ADXN 0.05
- Revenue
- RGF $156,379,000.00
- ADXN $960,641.00
- Revenue This Year
- RGF $23.67
- ADXN N/A
- Revenue Next Year
- RGF N/A
- ADXN N/A
- P/E Ratio
- RGF N/A
- ADXN $1.87
- Revenue Growth
- RGF 18.88
- ADXN N/A
- 52 Week Low
- RGF $0.21
- ADXN $5.00
- 52 Week High
- RGF $2.75
- ADXN $27.90
- Technical
- Relative Strength Index (RSI)
- RGF 45.74
- ADXN 64.36
- Support Level
- RGF $0.33
- ADXN $10.04
- Resistance Level
- RGF $0.40
- ADXN $10.81
- Average True Range (ATR)
- RGF 0.04
- ADXN 0.63
- MACD
- RGF 0.00
- ADXN 0.08
- Stochastic Oscillator
- RGF 56.82
- ADXN 86.17
About RGF The Real Good Food Company Inc.
The Real Good Food Company Inc is an high-growth, branded, health- and wellness-focused frozen food company. It develops, markets, and manufactures delicious and convenient comfort foods designed to be high in protein, low in sugar, and made from gluten- and grain-free ingredients that are intended to be sold in the health and wellness segment of the frozen food category. All of its revenue is derived from the United States.
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment which is the discovery, development and commercialization of small-molecule pharmaceutical products.